FT. LAUDERDALE, Fla.–(BUSINESS WIRE)–#AI–Anju Software has been named by Gartner as a sample vendor in four categories in its 2021 Hype Cycle Life Sciences Research and Development report [1] and Commercial Operations report. Anju’s work providing advanced software technology solutions across the clinical and commercial functions of life sciences was recognized in the “e-Clinical Platforms,” “Clinical Trial Data Transparency,” “Structured Content and Component Authoring” and “Key Opinion Leader Management” sections of the reports. Anju Software has also been recognized in the “Key Opinion Leader Management” category in the Gartner Hype Cycle for Life Science Commercial Operations, 2021.[2]

In the R&D space, Anju was named in the “e-Clinical platforms” category, which Gartner recognized as having a “transformational benefit” in their Priority Matrix for Life Science Research and Development, 2021. Additionally, in their Priority Matrix for Life Science Research and Development 2021, Gartner recognized three areas — e-Clinical Platforms, Clinical Trial Data Transparency (CTDT), and Structured Content Authoring (SBA) and Component Authoring (CBA) – as drivers impacting the digital acceleration of life sciences with the best opportunities to invest in within the next 2 to 5 years for mainstream adoption.

According to the Gartner Hype Cycle for Life Science Research and Development report, Anju is cited particularly in the following categories:

-e-Clinical Platforms that “support the end-to-end needs of clinical trial planning and execution and are composed of integrated solutions used for protocol development, electronic data capture (EDC), clinical trial management systems (CTMSs), randomization and trial supply management systems (RTSMs), electronic trial master files (eTMF), trial analytics and reports, and related capabilities that support clinical trial operations.”

-Clinical Trial Data Transparency (CTDT) which includes “tools and solutions for trial data redaction, anonymization, web portals and data storage and hosting, and trial registration with authorities, among other CTDT requirements.”

-Structured Content Authoring (SCA) and Component-Based Authoring (CBA) “that are the technologies and processes of managing data and content captured in activities used in life science regulatory filings.” Further the report states, “It decomposes documents, data and other content into discrete components that can be flexibly used and reassembled into different end requirements and change managed, resulting in greater activity and control for life sciences companies operating in complex, global regulatory frameworks.”

Additionally, in Gartner’s Hype Cycle for Life Science Commercial Operations report, Anju was recognized as a sample vendor of “Key Opinion Leader Management”. The Gartner report states that “Key Opinion Leader (KOL) systems are used to identify and build relationships with individuals who are influential in shaping peer healthcare providers’ (HCPs’) views on therapies.” The report further highlights that “Life science organizations’ adoption of KOL solutions is necessary as more scientifically complex and high-priced products enter the marketplace.” [2]

We believe this is an honor for Gartner to recognize how Anju is addressing areas critical to the continued growth of the life sciences sector,” said Suhas Gudihal, Chief Innovation Officer, Anju Software. “We continue to look forward to advance technologies that drive solutions for how clinical study and medical data, content and information is constructed and deconstructed, managed and distributed across healthcare ecosystems that streamline getting new therapies to patients.”

[1] Gartner, “Hype Cycle for Life Science Research and Development, 2021”, Jeff Smith, Michael Shanler, 19 July 2021

[2] Gartner, “Hype Cycle for Life Science Commercial Operations, 2021”, Animesh Gandhi, 14 July 2021

GARTNER and HYPE CYCLE are a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Anju Software

Anju Software provides an adaptive platform for clinical trials, medical affairs, and a newly designed, state-of-the-art clinical content and data repository. It’s an AI-based analytical solution combined with data and application integration capabilities, serving the worldwide pharmaceutical, biotech, and contract research Life Sciences markets.


Adam Nichols